Diabetic Retinopathy Market Size Growth Expects Significant Thrust at a CAGR of 3% During the Study Period, 2018-30 in the 7MM | DelveInsight - Seite 3

The Diabetic Retinopathy market encompasses several novel pipeline therapies with better efficiency and tolerability than conventional and available therapies. Key companies such as Novartis, Roche, Kodiak Sciences, Adverum Biotechnologies, Kubota Vision, Allegro Ophthalmics, and several others are developing new drugs that project a promising picture of the Diabetic Retinopathy market landscape in the coming decade. 

The market has limited options to offer, and a lack of gene therapy, personalized treatment approaches offer pharma companies a latitude to explore and penetrate with novel gene therapies, biosimilars into the market. 

This does not only promise one-time treatment but also facilitates the usage of lower doses ascribed to favorable anatomy of the eye owing to its size. Moreover, an increasing patient pool also gives pharma companies room for making cost-effective drugs without compromising with gains. Different possible pathways have been extensively studied, which could be responsible for the disease. Therefore, a better understanding has been obtained through years of thorough research and development. The emergence of personalized medications is expected to further drive the growth of the DR market share. 

Diabetic Retinopathy Pipeline Therapies and Key Companies

Brolucizumabt: Novartis Pharmaceuticals 
Faricimab: Roche 
ADVM-022: Adverum Biotechnologies
Emixustat Hydrochloride: Kubota Vision 
KVD001: KalVista Pharmaceuticals

Get a detailed analysis of Diabetic Retinopathy Emerging Drug Pipeline and Key Companies 

Scope of the Report 

Coverage: 7MM (the US, EU5, and Japan)
Study Period: 2018-30
Key Companies: Novartis, Roche, Adverum Biotechnologies, Kubota Vision, Kodiak Sciences andAllegro Ophthalmics.
Key Diabetic Retinopathy Pipeline Therapies: Brolucizumab, Faricimab, ADVM-022, Emixustat Hydrochloride, KVD001, KSI-301 and Risuteganib.
Diabetic Retinopathy Market Segmentation: By Geography, By Diabetic Retinopathy Therapies
Analysis: Comparative and conjoint analysis of Diabetic Retinopathy emerging therapies
Tools used: SWOT analysis, Conjoint Analysis, Porter's Five Forces, PESTLE analysis, BCG Matrix analysis methods.
Case Studies
KOL's Views
Analyst's Views

Drop by to learn more about the future market trends @ Diabetic Retinopathy Market Landscape and Forecast